Non-Invasive Cancer Therapy Pioneer Jeff Geschwind, MD advises HistoSonics on non-invasive liver tumor ablation, championing therapies that replace surgery. His leadership accelerates FDA-approved breakthroughs in focused ultrasound technology. https://www.bumc.bu.edu/camed/jean-francois-jeff-geschwind-m-d-91-2011-distinguished-alumnus-award/